Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ABEONA THERAPEUTICS INC. | 84,458 | reported | 26 Jan 2026 | tx 3+84,458 |
| Amylyx Pharmaceuticals, Inc. | 25,000 | reported | 05 Jun 2025 | tx 4+90,753 |
| Entrada Therapeutics, Inc. | 5,000 | reported | 20 May 2026 | tx 4+72,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 May 2026 | PURCHASE | Entrada Therapeutics, Inc. | 5,000 | 5.86 USD | first after silence |
| 26 Jan 2026 | GRANT_AWARD | ABEONA THERAPEUTICS INC. | 37,313 | 0.00 USD | |
| 11 Jun 2025 | GRANT_AWARD | Entrada Therapeutics, Inc. | 19,000 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 25,000 | 0.00 USD | deriv |
| 20 Mar 2025 | PURCHASE | Amylyx Pharmaceuticals, Inc. | 10,000 | 3.70 USD | |
| 31 Jan 2025 | GRANT_AWARD | ABEONA THERAPEUTICS INC. | 36,101 | 0.00 USD | |
| 13 Aug 2024 | GRANT_AWARD | ABEONA THERAPEUTICS INC. | 11,044 | 0.00 USD | |
| 13 Jun 2024 | GRANT_AWARD | Entrada Therapeutics, Inc. | 16,000 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 5,753 | 0.00 USD | deriv |
| 14 Mar 2024 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 50,000 | 0.00 USD | deriv |
| 04 Apr 2023 | GRANT_AWARD | Entrada Therapeutics, Inc. | 32,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 20 May 2026.